Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
Drug Saf. 2018 May;41(5):441-449. doi: 10.1007/s40264-017-0631-1.
Drug Saf. 2018.
PMID: 29332144
Review.